HIV-1 gp160 induces transforming growth factor-β production in human PBMC

Clinical Immunology and Immunopathology

Volumn 80, Issue 3 II, 1996, Pages 283-289

  Hu, Rong ^a   Oyaizu, Naoki ^a   Than, Soe ^a   Kalyanaraman, Vaniambadi S ^b   Wang, Xue Ping ^a   Pahwa, Savita ^a,c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b ADVANCED BIOSCIENCE LABORATORIES INC   (United States)

^c Division of Allergy/Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; MONOCYTE; PRIORITY JOURNAL;

ANTIBODIES; ANTIGENS, CD4; ANTIGENS, CD8; BASE SEQUENCE; CARBOHYDRATE SEQUENCE; CELLS, CULTURED; DRUG INTERACTIONS; GENE PRODUCTS, ENV; HIV ENVELOPE PROTEIN GP160; HUMANS; KINETICS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029797187     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0125     Document Type: Article

References (36)

1. Kehrl, J. H., Wakefield, L. M., Robert, A. B., Jakowlew, S., Alvarez-Mon, S., Derynck, R., Sporn, M. B., and Fauci, A. S., Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037-1050, 1986.
2. Kehrl, J. H., Robert, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., and Fauci, A. S., Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855-3860, 1986.
3. Assoian, R. K., Fleurdelys, B. E., Stevenson, H. C., Miller, P. J., Madtes, D. K., Raines, E. W., Ross, R., and Sporn, M. B., Expression and secretion of type β transforming growth factor by activated human macrophages. Proc. Natl. Acad. Sci. USA 84, 6020-6025, 1987.
4. Czarniecki, C. W., Chiu, H. H., Wong, G. H., MaCabe, S. M., and Palladino, M. A., Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140, 4217-4223, 1988.
5. Mule, J. J., Schwartz, S. L., Robert, A. B., Sporn, M. B., and Rosenberg, S. A., Transforming growth factor beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol. Immunother. 26, 95-100, 1988.
6. Kekow, J., Wachsman, W., McCutchan, J. A., Gross, W. L., Zachariah, M., Carson, D. A., and Lotz, M., Transforming growth factor-β and suppression of humoral immune responses in HIV infection. J. Clin. Invest. 87, 1010-1016, 1991.
7. Kekow, J., Wachsman, W., McCutchan, J. A., Cronin, M., Carson, D. A., and Lotz, M., Transforming growth factor-β and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 87, 8321-8325, 1990.
8. Navikas, V., Link, J., Wahren, B., Persson, C. H., and Link, H., Increased levels of interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection. Clin. Exp. Immunol. 96, 59-63, 1994.
9. Sattentau, Q. J., and Weiss, R. A., The CD4 antigen: Physiological ligand and HIV receptor. Cell 52, 631-633, 1988.
10. Kalyanaraman, V. S., Rodriguez, V., Veronese, F., Rahman, R., Lusso, P., DeVico, A. L., Copeland, T., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G., Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 6, 371-380, 1990.
11. Tyring, S. K., Cauda, R., and Kanda, P., Synthetic peptides corresponding to sequences in HIV envelope gp41 and gp120 enhance in vitro production of interleukin 1 and tumor necrosis factor but depress production of interferon-α, Interferon-γ and interleukin-2. Viral Immunol. 4, 33-42, 1991.
12. + T cell clone. J. Virol. 65, 6277-6282, 1991.
13. Than, S., Oyaizu, N., Pahwa, R. N., Kalyanaraman, V. S., and Pahwa, S., Effect of human immunodeficiency virus type 1 envelope glycoprotein gp160 on cytokine production from cord-blood T cells. Blood 84, 184-188, 1994.
14. Clouse, K. A., Cosentino, L. M., Weih, K. A., Pyle, S. W., Robbins, P. B., Hochstein, H. D., Natarajan, V., and Farrar, W. L., The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147, 2892-2901, 1991.
15. O'Connor-McCourt, M. D., and Wakefield, L. M., Latent transforming growth factor-beta in serum: A specific complex with alpha 2-macroglobulin. J. Biol. Chem. 262, 14090-14099, 1987.
16. Ikeda, T., Lioubin, M. N., and Marquardt, H., Human transforming growth factor type beta 2: Production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry 26, 2406-2410, 1987.
17. Tucker, R. F., Shipley, G. D., Moses, H. L., and Holley, R. W., Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226, 705-707, 1984.
18. Shull, M. M., Orsmby, I., Kier, AB., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proeztel, G., Calvin, D., Annunziata, N., and Doetschman, T., Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature 359, 693-699, 1992.
19. Christ, M., McCartney-Francis, N. L., Kulkarni, A. B., Ward, J. M., Mizel, D. E., Mackel, C. L., Hines, K. L., Tian, H., Karlsson, S., and Wahl, S. M., Immune dysregulation in TGF-β 1 deficient mice. J. Immunol. 153, 1936-1946, 1994.
20. Bodmer, S., Strommer, K., Frei, K., Siepl, C., Tribolet, D. N., Heid, L., and Fontana, A., Immunosuppression production of transforming growth factor-β in glioblastoma. J. Immunol. 143, 3222-3229, 1989.
21. Roszman, T., Elliott, L., and Brooks, W., Modulation of T-cell function by gliomas. Immunol. Today 12, 370-374, 1991.
22. Inge, T. H., Hoover, S. K., Susskind, B. M., Barree, S. K., and Bear, H. D., Inhibition of tumor-specific cytotoxic T-lymphocytes by transforming growth factor beta 1. Cancer Res. 52, 1386-1392, 1992.
23. - large granular lymphocyte function: Regulation of IL-2R β (p75) signal transduction. J. Immunol. 146, 3791-3798, 1991.
24. Massague, J., Cheifetz, S., Boyd, F. T., and Andres, J. L., TGF-β receptors and TGF-β binding proteoglycans: Recent progress in identifying their functional properties. Ann. N. Y. Acad. Sci. 593, 59-72, 1990.
25. Young, H. A., and Ortaldo, J. R., One-signal requirement for interferon-gamma production by human large granular lymphocytes. J. Immunol. 139, 724-727, 1987.
26. - lymphocytes. Natl. Immun. Cell. Growth Regul. 6, 28-33, 1987.
27. Kuppner, M. C., Hamou, M. F., Bodmer, S., Fontana, A., and Tribolet, N. de., The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int. J. Cancer 42, 562-568, 1988.
28. Barral-Netto, M., Barrai, A., Brownell, C. E., Skeiky, Y. A. W., Elingsworth, L. R., Twardzik, D. R., and Reed, S. G., Transforming growth factor-β in Leishmanial infection: A parasite escape mechanism. Science 257, 545-548, 1992.
29. + T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 24, 793-798, 1994.
30. Ameglio, F., Capobianchi, M. R., Castilletti, C., Cordiali, F. P., Fais, S., Trente, E., and Dianzani, F., Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells: Correlation with the induction of other cytokines. Clin. Exp. Immunol. 95, 455-458, 1994.
31. Borghi, P., Fantuzzi, L., Varano, B., Gessani, S., Puddu, P., Conti, L., Capobianchi, M. R., Ameglio, F., and Belardelli, F., Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 69, 1284-1287, 1995.
32. D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubil, M., and Trinchieri, G., IL-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178, 1041-1048, 1993.
33. Hu, R., Oyaizu, N., Kalynanraman, V. S., and Phawa, S., HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-γ and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro. Clin. Immunol. Immunopathol. 73, 245-251, 1994.
34. Nelson, B. J., Ralph, P., Green, S. J., and Nacy, C. A., Differential susceptibility of activated macrophage cytotoxic effects reactions to the suppressive effects of transforming growth factor-β1. J. Immunol. 146, 1849-1857, 1991.
35. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., and Srimai, S., Macrophage deactivating factor and transforming growth factors-β1, β2, β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944, 1990.
36. Chopra, R. K, Raj, N. B. K., Scally, J. P., Cappuccio, W. R., Nagel, J. E., Saah, A. J., and Margolick, J. B., Lack of role of TGF-β1 in decreased lymphoproliferative response in HIV-1 infection. Clin. Immunol. Immunopathol. 69, 77-82, 1993.